News

PhRMA, National Osteoporosis Foundation team on pipeline report

BY David Salazar
WASHINGTON — The National Osteoporosis Foundation and the Pharmaceutical Research and Manufacturers of America have teamed up on a new report covering the current state of the pipeline for osteoporosis drugs. 
 
The study found that there are currently nine medicines being developed, including five for postmenopausal osteoporosis, two for drug-induced osteoporosis and two specifically for men with osteoporosis. Additionally, there are 34 ongoing clinical trials studying osteoporosis treatments. 
 
“We are pleased to see that there continues to be progress made in the development of treatments for osteoporosis, but as our aging population continues to grow, there is more work to be done for patients,” PhRMA president and CEO Stephen J. Ubl said. “With 3 million bone fractures expected a year by 2025, biopharmaceutical companies are committed to advancing osteoporosis research and discovering new treatment options to help patients live longer, healthier lives.”
 
Osteoporosis affects nearly 54 million Americans, and by 2030 that number is expected to grow to more than 71 million people. Osteoporosis-caused broken bones affect half of women and a quarter of men over the age of 50. 
 
“We are encouraged by advancements in the research and development of treatments for osteoporosis,” National Osteoporosis Foundation president Dr. Robert F. Gagel. “New treatments and prevention efforts provide hope for a future in which fewer Americans suffer from the pain and disability this disease causes.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

TherapeuticsMD launches Rx prenatal that’s certified vegan and certified kosher

BY Michael Johnsen
BOCA RATON, Fla. – TherapeuticsMD recently announced the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaTrue, adding to its prenatal line consisting of vitaPearl, vitaMedMD One Rx, vitaMedMD Plus Rx and vitaMedMD RediChew Rx. 
 
VitaTrue offers women with vegan or kosher preferences and who are planning a pregnancy, pregnant or nursing a complete prenatal multivitamin without compromises. "VitaMedMD has once again listened and responded to the needs of women and the healthcare community for comprehensive nutritional support in the prenatal space, specifically creating a prenatal vitamin that is both certified vegan and certified kosher," stated Jason Spitz, VP marketing, TherapeuticsMD. "Like all vitaMedMD prenatal vitamins, vitaTrue is gluten-free, lactose-free and sugar-free.  Additionally, vitaTrue is fish-free and gelatin-free."
 
VitaTrue contains 16 vitamins and minerals, including 40% more folic acid than the leading prescription prenatal vitamins, and 300 mg of vegan, plant-based DHA. 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

New foot warmer from Pharma Supply fights winter chill

BY Gina Acosta

WELLINGTON, Fla. — Pharma Suppy Inc. is out with a simple solution to a sorely missed creature comfort: warm feet.

The company has launched the Advocate Foot Warmer, which provides relief from cold feet with four separate temperature settings. Serving double duty as a king-sized heating pad, the electric foot warmer features soft polar fleece lining that feels luxurious and helps to retain heat.

The foot warmer’s interior and exterior covers can easily be removed, and are machine washable. It has a nine foot cord to conveniently reach a chair or bed easily. To round out its features, the Advocate Foot Warmer has an auto off regulator.

Read more about it by clicking here.

For the user’s safety, it will automatically turn itself off when it has been used for two hours. The foot warmer is also a fantastic solution for office settings, which often prohibit space heaters and other bulky heating solutions.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?